Related Experiment Video
Updated: Jul 19, 2026

10:16
Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents
Published on: August 16, 2024
Poised for growth. Point-of-care testing.
Hospitals & Health Networks
|October 14, 2006
Summary
Point-of-care testing (POCT) offers rapid diagnostic results, with 70% occurring in healthcare settings. This segment is projected to grow significantly, outpacing home-based testing.
Area of Science:
- Medical Diagnostics
- Clinical Laboratory Science
Background:
- The United States leads the global market for diagnostic testing.
- Point-of-care testing (POCT) is a rapidly expanding segment within diagnostics.
- Increasingly compact, user-friendly, and accurate devices facilitate POCT in diverse settings.
Purpose of the Study:
- To provide an overview of point-of-care testing (POCT).
- To discuss the challenges and benefits of POCT, particularly for hospitals.
- To explore future trends in POCT.
Main Methods:
- The study provides a qualitative overview of the POCT market.
- It synthesizes information on common POCT applications and advantages.
- Expert predictions on future POCT growth are discussed.
Main Results:
- POCT offers significant speed advantages for diagnostic testing.
- Common POCT applications include blood glucose, blood gases, cardiac markers, sepsis, pregnancy, and ovulation tests.
- Despite home use, 70% of POCT occurs in provider locations.
Conclusions:
- POCT is a vital and growing component of the US diagnostic market.
- The segment is predicted to grow at an average annual rate of 15.5%, exceeding home-based testing growth.
- POCT offers substantial benefits for healthcare providers, emphasizing speed and accessibility.
Related Concept Videos
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Pulse Assessment Sites
Pulse assessment sites are crucial in evaluating a patient's cardiovascular health. By assessing the pulsations of arteries at specific anatomical locations, healthcare professionals can gather valuable information about blood flow, heart rate, and peripheral circulation. Understanding these pulse assessment sites is essential for conducting comprehensive cardiovascular evaluations and monitoring patients' overall health. These sites are strategically chosen due to the accessibility and...
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.

